Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy

Cell Reports(2023)10.1016/j.celrep.2023.113120Source: DataRank Database

MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.65)OA: goldTopics (57)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Roberto Giambruno ORCID,Claudia Caronni,Maria Pannese ORCID,Annapaola Andolfo ORCID,Davide Gabellini ORCID

Live enrichment

PubMed:37703175 OpenAlex:https://openalex.org/W4386637392

Ministero della Salute

Grant: RF-2018-12366631

National Institutes of Health

Grant: IA 52242

Fondazione Italiana per la Ricerca sul Cancro Airc

Grant: IG 2017-ID 19919

National Cancer Institute

Grant: 1R21CA249378-01

Regulation of human endogenous retroviruses in the context of cancer immunotherapy

European Commission

Grant: 267264

INternational VEnue for poSTgraduate education

NCI NIH HHS

Grant: R21 CA249378

FWCI

0.65

Citation Percentile

0.6%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124723011324/pdf

publisherhttp://www.cell.com/article/S2211124723011324/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124723011324?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124723011324?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2023.113120

Fields of Study

Muscle Physiology and DisordersRNA Research and SplicingAmyotrophic Lateral Sclerosis Research0301 basic medicine03 medical and health sciencesHumansAmyotrophic Lateral SclerosisGene Expression RegulationGenes, HomeoboxHomeodomain ProteinsMuscle, SkeletalMuscular Dystrophy, FacioscapulohumeralNeurodegenerative DiseasesNuclear Matrix-Associated ProteinsRNA-Binding Proteins

MeSH Terms

Amyotrophic Lateral SclerosisGene Expression RegulationGenes, HomeoboxHumansRNA-Binding ProteinsHomeodomain ProteinsMuscle, SkeletalNeurodegenerative DiseasesMuscular Dystrophy, FacioscapulohumeralNuclear Matrix-Associated Proteins

Keywords

Facioscapulohumeral muscular dystrophyTranscription factorMyopathyMuscular dystrophyBiologyCell biologyMyogenesisHomeoboxCancer researchMyocyteGeneticsGeneHomeodomain ProteinsFSHDDUX4QH301-705.5Amyotrophic Lateral SclerosisGenes, Homeoboxmuscle differentiationRNA-Binding ProteinsNeurodegenerative DiseasesArticleMuscular Dystrophy, Facioscapulohumeralcell toxicityGene Expression RegulationNuclear Matrix-Associated ProteinsHumansCP: Developmental biologyALSBiology (General)gene regulationMuscle, Skeletal

Sustainable Development Goals

SDG 0: Good health and well-being